Applied DNA Sciences Inc - נכסים נקיים למניה בודדת APDN
Applied DNA Sciences ensures supply chain transparency through the digital verification of DNA markers. Business protection is based on exclusive LinearRx patents under strict biocontrol conditions. Diversified transport routes guarantee the uninterrupted shipment of synthetic components. The adjusted book value per share clearly demonstrates the dynamics of net assets, where the 8.14 indicator expresses the current state of the metric.
פילוחי נתונים אנליטיים מרוכזים עבור adnas.com (APDN)
DNA component deliveries and the operations of LineaRx form the current material basis of Applied DNA Sciences (APDN), determining the actual net asset value. This metric measures the equity per share, reflecting the fundamental protection of investments through the value of equipment and inventories, which allows for an assessment of the business's intrinsic stability via the consolidated book value per share.